1.A case of Infectious Mononucleosis.
Hak Jun KO ; Eui Bon KOO ; Tai Gyu WHANG ; Soon Yong LEE
Journal of the Korean Pediatric Society 1986;29(1):113-
No abstract available.
Infectious Mononucleosis*
2.A case of infectious mononucleosis.
Yong Jin AHN ; Hae Youp KIM ; Hyung Jin CHUNG ; Hyun Ho SHIN ; Dong Hee CHO
Korean Journal of Infectious Diseases 1991;23(3):189-193
No abstract available.
Infectious Mononucleosis*
3.Splenic infarction associated with acute infectious mononucleosis.
Yuji SUZUKI ; Keisuke KAKISAKA ; Hidekatsu KURODA ; Tokio SASAKI ; Yasuhiro TAKIKAWA
The Korean Journal of Internal Medicine 2018;33(2):451-452
No abstract available.
Infectious Mononucleosis*
;
Splenic Infarction*
4.A Case of Infectious Mononucleosis with Fever and Cervical Lymphadenopathy.
Journal of the Korean Medical Association 1998;41(9):978-980
No abstract available.
Fever*
;
Infectious Mononucleosis*
;
Lymphatic Diseases*
5.One case of Infectious Mononcleosis.
Kyung Sook CHO ; Do Keum NA ; Byung Gyu KIM ; Sook Hyeon YUN ; Jong Dae JO ; In Sun JEON
Journal of the Korean Pediatric Society 1981;24(9):872-876
A case of infectious mononucleosis was presented. She was admitted to the hospital with the anterior cervical lymphadenopathy. Erythematous skin rashes on both low extermities, and splenomegaly. Her chief complaints were fever and sore throat. She showed atypical lymphocytes in peripheral blood smear with relative lymphocytosis. Mono-spot test was positive. She received symptomatic therapy and discharged without any complications. So, we report this case and review the brief literatures of infectious mononucleosis with the respect to etiology, clinical course, and histological characteristics of the disease.
Exanthema
;
Fever
;
Infectious Mononucleosis
;
Lymphatic Diseases
;
Lymphocytes
;
Lymphocytosis
;
Pharyngitis
;
Splenomegaly
6.Clinical effect of recombinant human interferon α1b adjuvant therapy in infectious mononucleosis: a prospective randomized controlled trial.
Chinese Journal of Contemporary Pediatrics 2020;22(9):953-957
OBJECTIVE:
To study the clinical effect of recombinant human interferon α1b assisting acyclovir on immune function, inflammatory factors, and myocardial zymogram in children with infectious mononucleosis (IM).
METHODS:
A total of 182 children with IM who were admitted to the hospital from January to December, 2018, were divided into an observation group with 91 children and a control group with 91 children using a random number table. The children in the control group were treated with intravenous drip of acyclovir, and those in the observation group were treated with inhalation of recombinant human interferon α1b in addition to the treatment in the control group. The two groups were compared in terms of clinical symptoms, immune function, inflammatory response, myocardial zymogram, and adverse reactions.
RESULTS:
Compared with the control group, the observation group had significantly shorter time to body temperature recovery and disappearance of isthmopyra, cervical lymph node enlargement, hepatomegaly, and splenomegaly (P<0.05). After treatment, both groups had significant increases in CD4, CD4/CD8, and CD19, and the observation group had significantly higher levels of these markers than the control group (P<0.05). After treatment, both groups had significant reductions in the levels of CD8+, tumor necrosis factor-α, interlukin-6, creatine kinase, and creatine kinase-MB, and the treatment group had significantly lower levels of these markers than the control group (P<0.05). There was no significant difference in the incidence rate of adverse reactions between the two groups after treatment (P>0.05).
CONCLUSIONS
For children with IM, recombinant human interferon α1b assisting acyclovir can effectively improve immune function, inhibit inflammatory reaction, reduce myocardial injury, and thus alleviate clinical symptoms.
Antigens, CD19
;
Hepatomegaly
;
Humans
;
Infectious Mononucleosis
;
Prospective Studies
;
Splenomegaly
8.Skin Rash in A Patient with Infectious Mononucleosis after the Intake of Ampicillin.
Tae Kee MOON ; Sung Nam CHANG ; Soo Chan KIM
Korean Journal of Dermatology 1994;32(6):1095-1098
During the course of infectious mononucleosis, intake of ampicillin and its analogues such as amoxicillin may cause hypersensitivity skin rashes. We report herein a case of ampicillin induced skin rash in a 41-year-old female patient with infectious mononucleosis. Infectious mononucleosis was confirrned by datetion of IgM antibody against Epstein-Barr(EB) viral capsid antigen(VCA) in her serum. During the icuteillness, she taked ampicillin for 3 days, and 1 week after the intake of ampicillin, a genertliz:d erythernatous and purpuric maculopapualr eruption developed. Physicians should be careful not to use ampicillin and its analogue if batients are suspected to be infected with EB virus as ampicillin induces severe skin rashes in patients with infectious mononucleosis.
Adult
;
Amoxicillin
;
Ampicillin*
;
Capsid
;
Exanthema*
;
Female
;
Humans
;
Hypersensitivity
;
Immunoglobulin M
;
Infectious Mononucleosis*
;
Skin*
9.Cytomegalovirus Infectious Mononucleosis in a Patient with a Gastric Ulcer.
Se Yoon PARK ; Eun Jung LEE ; Tae Hee LEE ; So My KOO ; Jin Nyoung KIM ; Min Huok JEON ; Eun Ju CHOO ; Tae Hyong KIM
Korean Journal of Gastrointestinal Endoscopy 2011;42(6):392-396
Cytomegalovirus (CMV) is a prevalent pathogen, with 98~100% of Korean adults showing prior exposure by serology. A primary infection, such as CMV infectious mononucleosis, is very rare. CMV infectious mononucleosis often presents an initial diagnostic problem. Patients are often hospitalized with a wide variety of clinical diagnoses including fever of unknown origin without pharyngitis and lymphadenopathy. CMV gastrointestinal infections are rare in previously immunocompetent individuals. The most common sites involved are the colon and rectum, although lesions of the stomach have also been described. It is unusual to see CMV infectious mononucleosis and CMV gastrointestinal infection in the same patient. Our patient received symptomatic treatment and fully recovered. We present a case of CMV infectious mononucleosis with gastric ulcers in a previously healthy adult.
Adult
;
Colon
;
Cytomegalovirus
;
Fever of Unknown Origin
;
Humans
;
Infectious Mononucleosis
;
Lymphatic Diseases
;
Pharyngitis
;
Rectum
;
Stomach
;
Stomach Ulcer
10.Evaluation of Real-time PCR Kits for Epstein-Barr Virus DNA Assays.
Jihye HA ; Yongjung PARK ; Jungeun SHIM ; Hyon Suk KIM
Laboratory Medicine Online 2016;6(1):31-35
BACKGROUND: Epstein-Barr virus (EBV) is known to be the causative agent of infectious mononucleosis and EBV-related malignancies. In this study, we compared the results of three real-time PCR kits for EBV DNA assays. METHODS: A total of 300 whole blood samples submitted for quantitative EBV PCR between January 2013 and September 2014 at Severance Hospital were included. The samples were tested by using the Artus EBV RG PCR Kit (Qiagen, Germany), AccuPower EBV Quantitative PCR Kit (Bioneer, Korea), and Real-Q EBV Kit (BioSewoom, Korea). Samples with discordant results between the three kits were confirmed by direct sequencing. RESULTS: The result concordance rate and kappa coefficient (K) were 86.3% and 0.69 for Artus-AccuPower, 93.3% and 0.85 for Artus-Real-Q, and 92.3% and 0.83 for AccuPower-Real-Q, respectively. The correlations between the three kits were found to be significant, with a correlation coefficient of r=0.854 for Artus-AccuPower, -0.802 for Artus-Real-Q, and -0.977 for AccuPower-Real-Q, respectively (P<0.0001). If the real-time PCR concordant results of 258 samples and the direct sequencing results of 42 real-time PCR discordant samples were assumed to be true, the sensitivity/specificity values were 0.921/0.976 for Artus, 0.902/0.965 for AccuPower, and 0.967/1.000 for Real-Q. CONCLUSIONS: The three real-time PCR kits showed excellent sensitivities and specificities. All these kits would be acceptable for clinical and therapeutic management of EBV. However, some discordant results between the kits indicate the need for caution in clinical diagnosis and staging. Further implementation of standardized methodology would be needed for EBV DNA assays.
Diagnosis
;
DNA*
;
Herpesvirus 4, Human*
;
Infectious Mononucleosis
;
Polymerase Chain Reaction
;
Real-Time Polymerase Chain Reaction*